BPC-157: what the published research covers
What the BPC-157 literature contains, which is mostly rat and cell studies, and where its US regulatory status stands in October 2026.
BlogCompound profiles Compound profiles Compound profiles Compound profiles Compound profiles
Research notes
What each compound is, what has been studied, and where it stands with US regulators. Every claim links to its source.
GHK-Cu: what the published research covers
GHK-Cu is a copper-binding tripeptide first described in human plasma in 1973. Here is what the studies show and how FDA lists it in 2026.
Melanotan II: what the published research covers
Melanotan II is a cyclic alpha-MSH analog tested in a few small 1990s trials. Here is the research, the case reports, and its 2026 FDA status.
MOTS-c: what the published research covers
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. Most data come from mice and cells. Here is the research and the 2026 FDA status.
Tesamorelin: what the published research covers
Tesamorelin is a GHRH analog approved by the FDA as Egrifta for one HIV-related indication. Here are the trials and its 2026 regulatory status.
Ordering opens soon.
Leave an email. We write once, the day checkout opens.